These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10860785)

  • 1. Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.
    Gearhart DA; Collins MA; Lee JM; Neafsey EJ
    Neurobiol Dis; 2000 Jun; 7(3):201-11. PubMed ID: 10860785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.
    Gearhart DA; Neafsey EJ; Collins MA
    Neurochem Int; 2002 Jun; 40(7):611-20. PubMed ID: 11900856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (R)salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes.
    Naoi M; Maruyama W; Nakao N; Ibi T; Sahashi K; Benedetti MS
    Ann Neurol; 1998 Feb; 43(2):212-6. PubMed ID: 9485062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of brain beta-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease.
    Gearhart DA; Neafsey EJ; Collins MA
    Neurochem Res; 1997 Feb; 22(2):113-21. PubMed ID: 9016836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases.
    Herraiz T; Guillén H; Galisteo J
    Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
    Maruyama W; Strolin-Benedetti M; Naoi M
    Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains.
    Naoi M; Maruyama W; Matsubara K; Hashizume Y
    Neurosci Lett; 1997 Oct; 235(1-2):81-4. PubMed ID: 9389601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease.
    MacDonald V; Halliday GM
    Mov Disord; 2002 Nov; 17(6):1166-73. PubMed ID: 12465053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
    Ferrer I; Perez E; Dalfó E; Barrachina M
    Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion.
    Helkamaa T; Reenilä I; Tuominen RK; Soinila S; Väänänen A; Tilgmann C; Rauhala P
    Neurochem Int; 2007; 51(6-7):412-23. PubMed ID: 17573159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
    Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: the first common neurological disease due to auto-intoxication?
    Williams AC; Cartwright LS; Ramsden DB
    QJM; 2005 Mar; 98(3):215-26. PubMed ID: 15728403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.